References
- Davis W A, Kane J G, Garagusi V F. Human Aeromonas infections: a review of the literature and a case report of endocarditis. Medicine 1978; 57: 267–277
- Jones B L, Wilcox M H. Aeromonas infection and their treatment. J Antimicrob Chemother 1995; 35: 453–461
- Gold W L, Salit I E. Aeromonas hydrophila infections of skin and soft tissue: report of 11 cases and review. Clin Infect Dis 1993; 16: 69–74
- Harris R L, Fainstein V, Elting L, Hopfer R L, Bodey G P. Bacteremia caused by Aeromonas species in hospitalized cancer patients. Rev Infect Dis 1985; 7: 314–320
- Vukmir R B. Aeromonas hydrophila: myofascial necrosis and sepsis. Intensive Care Med 1992; 18: 172–174
- Siddiqui M N, Ahmed I, Farooqi B J, Ahmed M. Myonecrosis due to Aeromonas hydrophila following insertion of an intravenous cannula: case report and review. Clin Infect Dis 1992; 14: 619–620
- Sanders C C. b˜-lactamases of gram-negative bacteria: new challenges for new drugs. Clin Infect Dis 1992; 14: 1089–1099
- Iaconis J P, Sanders C C. Purification and characterization of inducible b˜-lactamases in Aeromonas spp. Antimicrob Agents Chemother 1990; 34: 44–51
- Rossolini G M, Zanchi A, Chiesurin A, Amicosante G, Satta G, Gugliemetti P. Distribution of cphA or related carbapenemase-encoding genes and productions of carbapenemase activity in members of the genus Aeromonas. Antimicrob Agents Chemother 1995; 39: 346–349
- Shannon K, King A, Phillips I. b˜-lactamases with high activity against imipenem and Sch 34343 from Aeromonas hydrophila. J Antimicrob Chemother 1986; 17: 45–50